Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
Sabby Capital: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
Sabby Capital
Sabby Capital
Active
Website
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 2, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Apr 1, 2017
Epic Sciences
$40.0M Series D
Jerry Xiao
Deerfield Management
,
Domain Associates
,
Altos Capital Partners
, Frederic Pla
,
Pagoda Investment
,
Reach Tone Limited
,
RusnanoMedInvest
,
VI Ventures
Jan 6, 2015
Global Blood Therapeutics
$48.0M Series B
—
William Slattery
,
Perceptive Life Sciences
, RA Capital Management
,
Wellington Management
Dec 1, 2014
Naurex
$80.0M Series C
—
ALSA Ventures
,
Soffinova Partners
,
Adams Street Partners
, Baxter Ventures
, Cowen Healthcare Investments
,
Druid BioVentures
, Oleg Nodelman
,
Genesys Capital
,
Goudy Park Capital
,
H. Lundbeck
,
Latterell Venture Partners
,
Northwestern University
,
Portola Capital Partners
,
Savitr Capital
,
Takeda Ventures
Nov 12, 2014
Blueprint Medicines
$50.0M Series C
Alex Virgilio
BVF Partners
,
Casdin Capital
, Cowen Healthcare Investments
, F-Prime Capital
, Nextech Invest
,
Perceptive Advisors
, RA Capital Management
,
Redmile Group
,
Tavistock Group
,
Third Rock Ventures
,
Wellington Management
Aug 27, 2014
Bellicum Pharmaceuticals
$55.0M Series C
—
AJU IB Investment
,
AVG Ventures
,
Jennison Associates
, Joseph Edelman
, RA Capital Management
,
Redmile Group
,
Remeditex Ventures
,
Ridgeback Capital Investments
Aug 1, 2014
Dermira
$51.0M Series C
—
Canaan Partners
,
MPM Capital
,
Pivotal bioVenture Partners
, SR One Capital Management
, Aisling Capital
,
Apple Tree Partners
,
Bay City Capital
,
Canaan Partners
,
New Enterprise Associates
,
Rock Springs Capital
, UCB Ventures
Apr 1, 2014
Adverum Biotechnologies
$55.0M Series B
—
Venrock
,
Adage Capital Management
, Cowen Healthcare Investments
,
Deerfield Management
,
Redmile Group
,
Rock Springs Capital